Abanilla P. K. et al. (2005)
The use of psychostimulants in pervasive developmental disorders.
Psychiatric Quarterly
76(3), pp. 271-281
Medicines And Healthcare Products Regulatory Agency (2005)
Antipsychotic medicines: licensed products, uses and side effects.
Aman M. G. et al. (2005)
Acute and long-term safety and tolerability of risperidone in children with autism.
Journal of Child and Adolescent Psychopharmacology
15(6), pp. 869-884
Treatment planning for patients with autism spectrum disorders.
Journal of Clinical Psychiatry
66 pp. 38-45
Ayres K. M. , Langone J. (2005)
Intervention and instruction with video for students with autism: a review of the literature.
Education and Training in Developmental Disabilities
40(2), pp. 183-196
Baron-Cohen S. , Belmonte M. K. (2005)
Autism: a window onto the development of the social and the analytic brain.
Annual Review of Neuroscience
28 pp. 109-126
Bennett H. E. , Wood C. L. , Hare D. J. (2005)
Journal of Applied Research in Intellectual Disabilities
18(1), pp. 57-64
Bhardwaj A. , Agarwal V. , Sitholey P. (2005)
Asperger's disorder with co-morbid separation anxiety disorder: A case report.
Journal of Autism and Developmental Disorders
35(1), pp. 135-136
Bostic J. Q. , King B. H. (2005)
Autism spectrum disorders: emerging pharmacotherapy.
Expert Opinion on Emerging Drugs
10(3), pp. 521-536.
Complementary and alternative medicine in developmental disabilities.
Indian Journal of Pediatrics
72(11), pp. 949-952.
Focus on Autism and Other Developmental Disabilities
20(1), pp. 52-63
Listening to young people with special needs: the influence of group activities.
Journal of Intellectual Disabilities
9(4), pp. 359-376
Burrows K. E. , Adams C. L. (2005)
Guelph, Ontario: University of Guelph
Brain and Development
27(3), pp, 228-232